Published in

BioMed Central, Arthritis Research and Therapy, 5(16), 2014

DOI: 10.1186/s13075-014-0434-z

Links

Tools

Export citation

Search in Google Scholar

CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic ‘window of opportunity’

Journal article published in 2014 by Stinne Ravn Greisen ORCID, Karen Kraemmer Schelde, Tue Kruse Rasmussen, Tue Wenzel Kragstrup ORCID, Kristian Stengaard-Pedersen, Merete Lund Hetland, Kim Hørslev-Petersen, Peter Junker, Mikkel Østergaard, Mikkel Ostergaard, Bent Deleuran ORCID, Malene Hvid
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO